Seeing Is Believing

Currently out of the existing stock ratings of Jack Meehan, 52 are a BUY (46.85%), 41 are a HOLD (36.94%), 18 are a SELL (16.22%).
Analyst Jack Meehan, currently employed at BARCLAYS, carries an average stock price target met ratio of 92.73% that have a potential upside of 28.52% achieved within 284 days.
Jack Meehan’s has documented 231 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Consumer Cyclical, Basic Materials sectors.
Most recent stock forecast was given on QGEN, Qiagen NV.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%) receiving and performance score of 31.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Sep-2025
$90
8 months 25 days ago
(12-Jan-2026)
0/4 (0%)
$23.67 (35.69%)
Buy Since 05-Jan-2026
$78
$1.99 (2.62%)
$78
9 months 2 days ago
(05-Jan-2026)
22/25 (88%)
$3.25 (4.35%)
183
Hold Since 28-Jul-2022
$76
$-0.01 (-0.01%)
$69
10 months 27 days ago
(11-Nov-2025)
8/13 (61.54%)
$1.4 (1.88%)
72
Buy Since 13-Oct-2022
$78
$1.99 (2.62%)
$70
11 months 14 days ago
(23-Oct-2025)
5/14 (35.71%)
$4.11 (5.56%)
90
Buy Since 03-Feb-2022
$71
11 months 15 days ago
(22-Oct-2025)
4/10 (40%)
$16.84 (31.09%)
246
Which stock is Jack Meehan most bullish on?
Which stock is Jack Meehan most reserved on?
What Year was the first public recommendation made by Jack Meehan?